Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study.
To estimate the potential benefits of lowering systolic blood pressure (SBP) toward preventing late-life dementia, we estimated the population-attributable risk of elevated SBP for dementia. Analyses are based on the cohort of 8006 Japanese American men (born 1900-1919) followed since 1965 as a part of the Honolulu Heart Program, continued as the Honolulu Asia Aging Study. Midlife cardiovascular risk factors and late-life brain function are well described. We estimated the population-attributable risk of dementia cases attributed to midlife SBP, grouped by the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure criteria (<120, 120 to <140, and > or =140 mm Hg), taking into account treatment history, confounding factors, and competitive risk for death. The analysis is based on 7878 subjects, including 491 cases of dementia, with a mean interval of 25 years between measurement of blood pressure and dementia diagnosis. Compared with those with SBP <120 mm Hg, untreated, and <50 years of age at baseline, 17.7% (95% CI: 4.6% to 29.1%) of the cases were attributable to prehypertensive levels (SBP: 120 to <140 mm Hg) of SBP, translating into 11 excess cases per 1000. Among those who did not report taking antihypertensive medication in midlife, 27% (95% CI: 8.9% to 42.1%) of dementia cases can be attributed to systolic BP > or =120 mm Hg, translating into 17 excess cases per 1000. Although population-attributable risk estimates for population subgroups may differ by relative risk for dementia or prevalence of elevated levels of blood pressure, these data suggest that reducing midlife systolic BP is an effective prevention strategy to reduce risk for late-life dementia.
Launer
Lenore J
LJ
Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, Bethesda, MD 20892, USA. launerl@nia.nih.gov
Hughes
Timothy
T
Yu
Binbing
B
Masaki
Kamal
K
Petrovitch
Helen
H
Ross
G Webster
GW
White
Lon R
LR
D000367:Age Factors; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001294:Attitude to Health; D001795:Blood Pressure Determination; D003072:Cognition Disorders / Q000209:etiology / Q000517:prevention & control; D015331:Cohort Studies; D016001:Confidence Intervals; D003704:Dementia / Q000209:etiology / Q000517:prevention & control*; D005500:Follow-Up Studies; D006254:Hawaii; D006293:Health Promotion; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011322:Primary Prevention / Q000379:methods*; D011336:Probability; D016016:Proportional Hazards Models; D011634:Public Health / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index; D013599:Systole / Q000187:drug effects; D016896:Treatment Outcome
D000959:Antihypertensive Agents
Neurology. 2001 Jun 26;56(12):1683-9
11425934
Diabetes Care. 1999 Aug;22(8):1262-5
10480768
Neurology. 2005 Jan 25;64(2):277-81
15668425
Stroke. 2002 Jan;33(1):26-30
11779884
Am J Epidemiol. 1975 Dec;102(6):477-80
1202949
Neurobiol Aging. 2000 Jan-Feb;21(1):49-55
10794848
Neurobiol Aging. 2000 Jan-Feb;21(1):57-62
10794849
BMJ. 2001 Jun 16;322(7300):1447-51
11408299
JAMA. 1996 Sep 25;276(12):955-60
8805729
Stroke. 2006 May;37(5):1165-70
16601212
Clin Infect Dis. 2005 Apr 15;40(8):1079-86
15791504
Neurology. 2005 Sep 27;65(6):876-81
16186527
Hypertension. 2004 Jul;44(1):29-34
15159381
Am J Clin Nutr. 2000 Nov;72(5):1074-81
11063431
Neurology. 1999 Mar 23;52(5):971-5
10102414
Hypertension. 1998 Mar;31(3):780-6
9495261
Stroke. 1999 Mar;30(3):529-36
10066847
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD004034
19821318
Curr Opin Cardiol. 1999 Mar;14(2):79-83
10191964
Am J Public Health. 1998 Jan;88(1):15-9
9584027
Lancet Neurol. 2005 Aug;4(8):487-99
16033691
Am J Cardiol. 1971 Apr;27(4):335-46
5572576
Neurology. 2000;54(11 Suppl 5):S16-20
10854356
Int Psychogeriatr. 1994 Spring;6(1):45-58; discussion 62
8054493
Neurology. 1999 Jan 1;52(1):78-84
9921852
JAMA. 1995 Dec 20;274(23):1846-51
7500533
Stat Methods Med Res. 2001 Jun;10(3):195-216
11446148
JAMA. 2006 Nov 15;296(19):2343-50
17105797
Neurology. 1992 Mar;42(3 Pt 1):473-80
1549205
Lancet. 1990 Mar 31;335(8692):765-74
1969518
Epidemiol Rev. 1991;13:294-314
1765115
Hypertension. 2003 Dec;42(6):1206-52
14656957
Lancet. 2002 Dec 14;360(9349):1903-13
12493255
J Neurol Sci. 2004 Nov 15;226(1-2):13-7
15537512
Am J Cardiol. 2004 Dec 15;94(12):1496-500
15589003
Lancet Neurol. 2008 Aug;7(8):683-9
18614402
J Am Geriatr Soc. 2007 Jul;55(7):1056-65
17608879
Neurology. 1984 Jul;34(7):939-44
6610841
Neurology. 2005 Jan 25;64(2):263-7
15668423
Neurology. 2000 Apr 11;54(7):1526-9
10751272